4.6 KiB
AVGO Investment Analysis & Decision
Evaluating the Proposed Investment Plan
Strengths of the Analysis
The proposed plan demonstrates sophisticated thinking by integrating both fundamental and technical perspectives rather than dismissing either. Let me verify the key claims and stress-test the framework.
Fundamental Assessment
| Metric | Value | Assessment |
|---|---|---|
| Quarterly FCF | ~$8B | Exceptional cash generation |
| Revenue Growth | ~29% YoY | High-quality growth |
| Forward P/E | ~17.6x | Compelling vs. growth rate |
| PEG Ratio (implied) | ~0.6x | Significantly undervalued on growth-adjusted basis |
| Market Cap Drawdown | ~$475B erased | Substantial pessimism already priced |
The fundamental case is genuinely strong. A 17.6x forward P/E for a company growing at 29% with $8B quarterly FCF is difficult to dismiss, even in a risk-off environment.
Technical Risk Assessment
Bearish Signals Confirmed:
- Price below all major moving averages
- Pattern of lower highs and lower lows
- Failed March recovery attempt
- MACD negative at -3.53 and reaccelerating lower
- RSI not yet at extreme oversold levels
The technical picture is unambiguously broken in the near term. This cannot be rationalized away.
Critical Risk Factors
1. The DeepSeek/AI Efficiency Risk
The bear's strongest point deserves weight: Q1 results reflect pre-DeepSeek order books. The real test arrives in Q2-Q3 when we see whether hyperscalers adjusted XPU orders after efficiency gains from smaller model architectures became apparent.
2. Gap Risk (Bull's Strongest Point)
AVGO's earnings moves of 8-12% are historically documented. Waiting for confirmation after a catalyst gap could mean entering at 330-340 versus 310 — a materially worse risk/reward entry.
3. The Failed Scenario Problem
The bear correctly notes the gradual recovery scenario was attempted and failed in March. Assigning 50% probability to a scenario with a recent failed attempt is intellectually dishonest. I weight this at 25-30%.
Probability-Weighted Scenario Analysis
| Scenario | Probability | 12M Price Target | Weighted Return |
|---|---|---|---|
| Full recovery + earnings beat | 30% | $380 | +$21.00 |
| Gradual recovery to 200-DMA | 25% | $355 | +$11.25 |
| Sideways consolidation | 25% | $310 | $0.00 |
| Technical breakdown, thesis impaired | 20% | $250 | -$12.00 |
| Expected Return | ~+$20.25 (~6.5%) |
At a 1/3 position with stop at $285, maximum loss on initial tranche is approximately 8%, creating an asymmetric setup.
Modifications to the Proposed Plan
I accept the staged accumulation framework with the following refinements:
Position Sizing
- Tranche 1 (~310): 1/3 position — Establish now
- Tranche 2 (~295-308 with RSI <30 bounce): 1/3 position — Add on technical confirmation of support
- Tranche 3: Either post-Q2 earnings beat OR break above $330 with positive MACD — Add on fundamental confirmation
Hard Stop
- $285 firm stop on full position — below double-bottom support, signals potential fundamental impairment
Watch List for Invalidation
- Q2 guidance with any cautionary language on XPU order rates
- Hyperscaler capex guidance cuts (MSFT, GOOGL, META earnings)
- MACD further deteriorating below -5.0 without price stabilization
Why I'm Not Following the Bear Case Entirely
Sitting completely on the sidelines for a business with:
- $32B annualized FCF
- 17.6x forward earnings
- 29% revenue growth
...during maximum pessimism has a real opportunity cost. The bear's "wait for confirmation" strategy systematically underweights gap risk on positive catalysts. Being absent when the turn happens in a name like AVGO means potentially chasing a 10-12% gap at worse risk/reward.
The staged approach is the answer to this dilemma — it respects technical risk through position sizing while not leaving you entirely exposed to upside gap risk.
Final Decision Summary
Action: BUY (Staged Accumulation — Tranche 1)
- Entry: ~$310 current levels
- Position Size: 1/3 of intended full position
- Stop Loss: $285 (hard stop, full position)
- Base Case Target: $350-360 (12 months)
- Bull Case Target: $380 (12 months)
- Risk/Reward on initial tranche: Approximately 1:2 (8% risk vs. 13-16% base case return)
The technical risk is real and respected through position sizing. The fundamental opportunity is exceptional and respected through initiating exposure rather than sitting entirely on the sidelines.
FINAL TRANSACTION PROPOSAL: BUY